Insulin

Hypoglycemia occurs when your blood sugar levels drop below the normal range. This can happen for several reasons, including skipping meals, excessive insulin use, certain medications, or underlying medical conditions.

Diabetes breakthrough: Chinese trial opens path to an insulin-free future

In a revolutionary medical procedure, insulin-producing cells derived from a young woman’s own body were successfully implanted, freeing her from the need for daily insulin injections.

FTC sues drug middlemen over manipulating insulin market

The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved drugs

What is Type 1.5 diabetes, symptoms of this hard-to-diagnose diabetes, and tips to manage it

Type 1.5 diabetes, or LADA, is often misdiagnosed due to features similar to those of Type 1 and 2 diabetes. It requires a precise diagnosis and a combination of lifestyle changes, medication, and insulin therapy. Here's what you should know to identify and better manage the condition.

Type 1 diabetes in children: Causes, symptoms, expert tips on ways to manage the condition

Diabetes in children: Managing Type 1 diabetes requires a comprehensive approach, including medical care, lifestyle adjustments, and ongoing education for both the child and their family. Use these expert tips to manage the conditions effectively and avoid the risk of worsening health conditions.

Once-in-a-week insulin jab nears approval in India: Report

Insulin Icodec, the first weekly insulin jab from Novo Nordisk, which also makes weight-loss drug Ozempic, is expected to be a significant advancement in managing diabetes

Menopause: All about heart health risks and preventive measures

Menopause typically occurs between the age of 45 and 55, marking the end of a woman's reproductive years. It is characterised by a significant decline in estrogen levels. Estrogen plays a crucial role in maintaining heart and blood vessel health by helping to manage cholesterol levels, promoting vasodilation and possessing anti-inflammatory properties.

Arvind Kejriwal & K Kavitha's Judicial Custody Extended | Tihar Officials Gave Insulin To Kejriwal

Delhi's Rouse Avenue court on April 23 extended the judicial custody of Delhi Chief Minister Arvind Kejriwal and BRS leader K Kavitha in a money laundering case related to the alleged excise scam. Their custody has been extended till May 7. Kaveri Baweja, special judge for CBI and ED matters, extended their custody after they were produced before the court through video conference on expiry of their remand. Watch for more

Arvind Kejriwal arrest: Why mangoes and insulin became contentious issues

On April 19, Kejriwal filed an application at a Delhi court, asking it to allow the jail authorities to administer insulin and permit him to consult Dr Ravichandra Rao through videoconferencing for 15 minutes everyday.

Neither advised any insulin nor any requirement indicated: Tihar officials in report to L-G on Kejriwal's request

The administration stated that there is adequate availability of insulin in the jail dispensary and can be administered to Kejriwal as and when required.

Beetroot, the superfood to increase stamina, boost insulin sensitivity, regulate blood pressure

Health benefits of beetroot: Bright coloured and earthy in flavour, beetroot is as healthy as it looks. Powered with nitrates, vitamins, and minerals, this crimson-coloured root vegetable is a superhero that that guards you against an array of health woes.

What to eat: Include beetroot in your healthy diet to check insulin sensitivity, control haemoglobin level

Beetroot health benefits: Beetroot, a highly nutritious vegetable, is gaining popularity as a functional food for its health benefits, including improved digestion, cancer risk reduction, enhanced insulin sensitivity, better blood count, and improved athletic performance, making it a valuable addition to a balanced diet.

Health benefits of cinnamon: The go-to super spice to fight PCOS, check blood sugar, boost immunity

Health benefits of cinnamon: Beyond its culinary charm, cinnamon is a health powerhouse. From regulating blood sugar to nurturing heart health, boosting immunity, and halting cancer cell growth, this aromatic spice offers an array of health benefits.

Efforts on to launch once-a week- insulin in India by mid-2025: Novo Nordisk MD

Danish pharma giant working on launching Icodec. India managing director and corporate vice-president Vikrant Shrotriya says the company also has a plan to launch anti-obesity drug, Wegovy, in India but it may not happen very soon.

ICMR releases guidelines for type-1 diabetes as cases rise among children

The council highlights steps to check the rising cases of type-1 diabetes among the Indian population.

Smart insulin is the future: Vikrant Shrotriya of Novo Nordisk

If taking an insulin injection every day is difficult for a diabetes patient, a once-a-week option would probably be more acceptable in the future.

Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen

“This will enable us to serve over 400,000 people with diabetes using recombinant human insulin, helping the government on its journey towards equitable access to diabetes care,” said Susheel Umesh, chief commercial officer, emerging markets, Biocon Biologics.

Wockhardt antibiotic expected to hit US in FY21, market worth $1.5 bn: Khorakiwala

Wockhardt on Monday said the pay-off of its two-decade old research into antibiotics looks within striking distance, as its drug to treat superbugs is expected to hit the US market somewhere in 2020-21.

Biocon ties up with Ypsomed to launch latter's reusable pen injector in Malaysia

Ypsomed’s reusable pen compliments Biocon's insulins product portfolio and enables Biocon to further address the growing needs of people with diabetes in Malaysia, the company said.

Biocon gains 5% on strong Q3 numbers; wins Rs 460 crore contract

The company's Q3 (Oct-Dec) consolidated net profit jumped 64.6 percent to Rs 171.3 crore from Rs 104.1 crore, in the same quarter last fiscal.

J&J warns diabetic patients: Insulin pump vulnerable to hacking

Medical device experts said they believe it was the first time a manufacturer had issued such a warning to patients about a cyber vulnerability, a hot topic in the industry following revelations last month about possible bugs in pacemakers and defibrillators.

Trastuzumab marketing approval may come in 12-18 months: Biocon

The European Medicines Agency (EMA) has accepted to review Mylan and Biocon‘s application for a biosimilar called Trastuzumab, used for certain breast and gastric cancers.

Biocon shares fall after US firm opts out of insulin project

In 2012, Biocon and BMS had signed an agreement to jointly develop oral forms of insulin - an ambitious project spearheaded by the Indian biotech company.

Biocon gets approval for insulin Glargine in Mexico

The company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement.

Biocon up 3% post Mylan's phase-3 trials for Glargine

Kiran Mazumdar Shaw, CMD of the company sees it to be a huge opportunity in the diabetic market and expects the insulin analogue market to grow in double-digits.